Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00EGV
|
|||
| Drug Name |
Monoamine derivative 2
|
|||
| Synonyms |
PMID26815044-Compound-95
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Albinism [ICD-11: EC23.2; ICD-10: E70.3, H90.3] | Patented | [1] | |
| Ephelides [ICD-11: ED61.0] | Patented | [1] | ||
| Melasma [ICD-11: ED60.1] | Patented | [1] | ||
| Menkes disease [ICD-11: 5C64.0; ICD-10: E83.0] | Patented | [1] | ||
| Senile lentigines [ICD-11: ED61.0] | Patented | [1] | ||
| Company |
UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H21NO
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCNCC2=CC(=CC=C2)OC3=CC=CC=C3
|
|||
| InChI |
1S/C21H21NO/c1-3-8-18(9-4-1)14-15-22-17-19-10-7-13-21(16-19)23-20-11-5-2-6-12-20/h1-13,16,22H,14-15,17H2
|
|||
| InChIKey |
VXWOCJGIIONIQR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tyrosinase (TYR) | Target's Patent Info | [1] | |
| BioCyc | (S)-reticuline biosynthesis | |||
| Eumelanin biosynthesis | ||||
| L-dopachrome biosynthesis | ||||
| KEGG Pathway | Tyrosine metabolism | |||
| Riboflavin metabolism | ||||
| Metabolic pathways | ||||
| Melanogenesis | ||||
| Pathwhiz Pathway | Riboflavin Metabolism | |||
| Tyrosine Metabolism | ||||
| WikiPathways | Dopamine metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tyrosinase inhibitors: a patent review (2011-2015).Expert Opin Ther Pat. 2016;26(3):347-62. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.